Results 161 to 170 of about 70,860 (294)

Precision nutrition in weight loss and neuroendocrine control of people with obesity: The study protocol of a factorial randomised controlled trial (GenON Programme)

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Precision nutrition, guided by genetic testing, has emerged as a promising approach for managing obesity. However, robust clinical trials testing its effectiveness in real‐world dietary interventions remain scarce. The GenOn Programme aims to evaluate whether tailoring nutritional care based on genetic risk for obesity enhances weight ...
Karla P. Balbino, Ana Claudia P. Kravchychyn, Flávia G. Cândido, Mariana de Moura e Dias, Tiago Antônio de O. Mendes, Leandro Licursi de Oliveira, Luiza Carla V. Castro, Josefina Bressan, Ana Laura de la Garza, Fermín I. Milagro, María A. Zulet, Helen Hermana M. Hermsdorff   +11 more
wiley   +1 more source

Role of fasting glucose and glycated hemoglobin for gestational diabetes mellitus diagnosis: A prospective study. [PDF]

World J Diabetes
Molina-Vega M, Estébanez-Prieto MJ, Fernández-Valero A, Lima-Rubio F, Fernández-Ramos AM, Linares-Pineda TM, Morcillo S, Picón-César MJ.   +7 more
europepmc   +1 more source

[Estimation of glycated hemoglobin values as a mathematical model].

Klinicheskaia laboratornaia diagnostika, 2006
By using various assays of glycated hemoglobin, the author deduced a model of this index by its level, association with major metabolic parameters from the linear and nonlinear correlations and regression. The duration of diabetes mellitus, serum total cholesterol, and postprandial glycemia were found to have the most considerable impact on the ...
openaire   +1 more source

Glycated hemoglobin: A powerful tool not used enough in primary care.

, 2018
BACKGROUND: Glycated haemoglobin (HbA1c) is one of the most useful and relevant laboratory tests currently available. The aim of the actual research was to study the variability and appropriateness in the request of HbA1c in primary care, and differences between regions, to assess if there would be an opportunity to improve the request.
Salinas M, López-Garrigós M, Flores E, Leiva-Salinas C, Pilot Group of the Appropriate Utilization of Laboratory Tests   +4 more
openaire   +3 more sources

Efficacy and safety of switching basal insulin to insulin glargine 300 U/mL in individuals with inadequately controlled type 2 diabetes on advanced insulin therapies: The Toujeo‐Neo T2DM study

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims This real‐world study evaluated the effectiveness and safety of switching basal insulin (BI) to insulin glargine 300 U/mL (Gla‐300) in adults with inadequately controlled type 2 diabetes mellitus (T2DM), previously receiving basal‐supported oral therapy plus prandial insulin (BOTplus) or multiple (≥3) daily injections (MDI) of short ...
Stefan Pscherer, Andreas Fritsche, Helmut Anderten, Katrin Pegelow, Henry Y. Han, Martin Pfohl, Jochen Seufert   +6 more
wiley   +1 more source

The impact of glycated hemoglobin trajectories on hypertension risk: a retrospective cohort study. [PDF]

Front Nutr
Sun Y, Shen Y, Liu A, Zhao C, Ji X, Li X, Zou Z, Li Z, Wu X, Wang Y, Liu M, Li Y, Hao Y.   +12 more
europepmc   +1 more source

Increased Levels of Glycated Hemoglobin A1c and Iron Deficiency Anemia: A Review

, 2019
Wenjia Guo, Qi Zhou, Yanan Jia, Jiancheng Xu   +3 more
openalex   +2 more sources

Effects of age and disease duration on the glycaemic outcomes and safety of insulin glargine 300 U/mL in people with type 2 diabetes in China: A post‐hoc analysis of the INITIATION study

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To evaluate the glycaemic outcomes and safety of insulin glargine 300 U/mL (Gla‐300) in Chinese people with uncontrolled type 2 diabetes (T2D) by baseline age and disease duration. Materials and Methods INITIATION was a 24‐week, interventional, single‐arm study where adults with T2D (glycated haemoglobin [HbA1c] 7.5%–11.0%) received Gla ...
Liming Chen, Qiu Zhang, Binhong Duan, Xiaohong Wu, Hailong Wan, Binhong Wen, Jie Han, Haixia Liu, Caixian Yang, Weiwei Liu, Qin Du, Lei Kang, Minlu Zhang   +12 more
wiley   +1 more source

Analysis of the Relationship Between Glycated Hemoglobin and Echocardiographic Parameters in Patients Without Diabetes: A Retrospective Study. [PDF]

J Clin Med
Jakubiak GK, Pawlas N, Starzak M, Blachut D, Chwalba A, Wojciechowska C, Cieślar G.   +6 more
europepmc   +1 more source

Age disparities in SGLT2 inhibitor prescription among people with type 2 diabetes: The role of frailty and sex

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Background Older adults with type 2 diabetes (T2DM) are less likely to receive sodium–glucose cotransporter‐2 (SGLT2) inhibitors, despite their proven cardio‐renal benefits and safety. Whether this age‐related gap is driven by frailty, sex, or other factors remains unclear.
Changyuan Yang, Petra Denig, Lynne Chepulis, Ryan G. Paul, Jung‐Im Shin, Ron T. Gansevoort, Priya Vart   +6 more
wiley   +1 more source